These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 21794204)

  • 1. Gram-negative outer membrane vesicles in vaccine development.
    Collins BS
    Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
    Yi J; Liu Q; Kong Q
    Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application.
    Furuyama N; Sircili MP
    Biomed Res Int; 2021; 2021():1490732. PubMed ID: 33834062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in gram-negative bacterial outer membrane vesicles.
    Lee EY; Choi DS; Kim KP; Gho YS
    Mass Spectrom Rev; 2008; 27(6):535-55. PubMed ID: 18421767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development.
    Valguarnera E; Feldman MF
    Methods Enzymol; 2017; 597():285-310. PubMed ID: 28935107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
    Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
    mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial ghosts as multifunctional vaccine particles.
    Szostak MP; Mader H; Truppe M; Kamal M; Eko FO; Huter V; Marchart J; Jechlinger W; Haidinger W; Brand E; Denner E; Resch S; Dehlin E; Katinger A; Kuen B; Haslberger A; Hensel A; Lubitz W
    Behring Inst Mitt; 1997 Feb; (98):191-6. PubMed ID: 9382740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis.
    Persson G; Pors SE; Thøfner ICN; Bojesen AM
    Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMV Vaccines and the Role of TLR Agonists in Immune Response.
    Mancini F; Rossi O; Necchi F; Micoli F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
    Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
    Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
    Holst J; Feiring B; Naess LM; Norheim G; Kristiansen P; Høiby EA; Bryn K; Oster P; Costantino P; Taha MK; Alonso JM; Caugant DA; Wedege E; Aaberge IS; Rappuoli R; Rosenqvist E
    Vaccine; 2005 Mar; 23(17-18):2202-5. PubMed ID: 15755595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of Gram-negative bacterial outer membrane vesicles: Current perspectives.
    Lee J; Kim OY; Gho YS
    Proteomics Clin Appl; 2016 Oct; 10(9-10):897-909. PubMed ID: 27480505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
    Lei EK; Azmat A; Henry KA; Hussack G
    Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.
    Uli L; Castellanos-Serra L; Betancourt L; Domínguez F; Barberá R; Sotolongo F; Guillén G; Pajón Feyt R
    Proteomics; 2006 Jun; 6(11):3389-99. PubMed ID: 16673438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.